Advanced glycoxidation end products in patients with multiple sclerosis.

Prague medical report

Volumn 106, Issue 2, 2005, Pages 167-174

  Kalousova M ^a   Havrdova E ^a   Mrazova K ^a   Spacek, P ^a   Braun, M ^a   Uhrova J ^a   Germanova A ^a   Zima, T ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; ARGININE; DRUG DERIVATIVE; IMMUNOGLOBULIN RECEPTOR; LYSINE; MYELIN BASIC PROTEIN; PENTOSIDINE;

ADULT; ARTICLE; FEMALE; HUMAN; MALE; METABOLISM; MULTIPLE SCLEROSIS; PROTEIN CEREBROSPINAL FLUID LEVEL;

ADULT; ARGININE; CEREBROSPINAL FLUID PROTEINS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYSINE; MALE; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; RECEPTORS, IMMUNOLOGIC;

EID: 33644810396     PISSN: 12146994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)